Treatment of breast cancer cell line with Crocetin reduced metastasis rate by suppressing MMP-2 activity and inhibition of pro-MMP-9 conversion to MMP-9 (Chryssanthi et al., 2011[4]). The gene discussed is MMP9; the disease is breast carcinoma.